CompuGroup Medical Societas Europaea



PE Ratio
Market Cap
52 Week Range
$56.53 - $96.50
Operating Margin
Dividend & Yield
$0.56 (0.99%)
Rev. per Share

About CompuGroup Medical Societas Europaea

Compugroup Medical SE & Co. KGaA develops and sells software and information technology services for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment provides practice management software and electronic medical records for doctors in private practice, medical care centers, and doctor's networks, as well as offers supplementary Internet and intranet solutions. The PCS segment provides integrated clinical, administrative, and billing-related software applications for pharmacies, as well as in-store and online merchandising programs supported by paper-based and electronic communication and advertising solutions. The HIS segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute care hospitals; rehabilitation centers; and social services, including multi-location hospital networks and regional care organizations. The CHS segment provides communication and data solutions that allow pharmaceutical companies to provide information to healthcare providers through software interfaces. This segment offers clinical decision support systems, and medications and therapy databases for healthcare providers; and personal health records, consumer portals, and mobile applications solutions for healthcare IT companies, as well as collects and transfers anonymous clinical data for market studies, clinical trials, etc. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical SE and changed its name to Compugroup Medical SE & Co. KGaA in June 2020. Compugroup Medical SE & Co. KGaA is headquartered in Koblenz, Germany.


News about CompuGroup Medical Societas Europaea

CompuGroup Medical Societas Europaea

Health Information Services
About kinfo
Kinfo is an app for DIY traders and investors. Kinfo tracks your trading performance and lets you compare measurable performance metrics against other traders. Kinfo works for day trading, swing trading and longer holding periods. By tracking portfolio performance kinfo allows traders to learn, find inspiration and gain confidence.
Get Social
Download the App

Trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.

Never risk more than you are willing to lose. Trading futures and other derivatives may cause losses that exceed deposits.

Hypothetical performance results have inherent limitations, some of which are described below. Kinfo makes no representation that any trading account will or is likely to achieve profits or losses like those shown. There are often sharp differences between hypothetical trading performance results and the actual results subsequently achieved by any trading program. Past results of advertised trading systems, profit statements, charts or any other representations are not indicative of future performance.

Kinfo is an educational site and is not a financial adviser or broker. All stocks, ETFs, commodities, Indices, Forex, Bonds, and other securities mentioned in our courses are for educational and illustrative purposes only. If you need professional investment advice, please consult a registered investment adviser. Futures and Options carry risk and may not be suitable for everyone.

Kinfo demonstrates specific advanced approaches (or methods). Any mention of Return of Investment percentages is only indicative of the potential of the strategy or the system and is not meant to signify any guaranteed returns.

Success in trading involves a range of human factors like decision making skills, adjustment skills, emotional control, and risk management and other psychological and behavioral parameters, all of which are completely in the hands of the individual. Trading involves significant risk of loss. It is not suitable for all investors.

Charts on kinfo provided by TradingView